Although B cell content appeared to be slightly higher in patients who responded to anti-PD-1 than patients who did not, this did not reach statistical significance in this cohort.
← all excerpts
B cell depletion or absence does not impede anti-tumor activity of PD-1 inhibitors.
1
—
—